...
首页> 外文期刊>FEBS Letters >Biomarker evidence of DNA oxidation in lung cancer patients: association of urinary 8‐hydroxy‐2′‐deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment
【24h】

Biomarker evidence of DNA oxidation in lung cancer patients: association of urinary 8‐hydroxy‐2′‐deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment

机译:肺癌患者DNA氧化的生物标志物证据:尿中8-羟基-2'-脱氧鸟嘌呤排泄与放疗,化疗和治疗反应的关系

获取原文
   

获取外文期刊封面封底 >>

       

摘要

>Ratios of urinary 8-hydroxy-2′-deoxyguanosine to urinary creatinine (8-OHdG/creatinine) have been considered as a good biological indicator of DNA oxidation. Urinary 8-OHdG/creatinine levels of lung cancer patients were evaluated by enzyme-linked immunosorbent assay using a monoclonal antibody N45.1 during radiotherapy and chemotherapy. An increase in urinary 8-OHdG/creatinine was found in non-small-cell carcinoma (non-SCC) patients during the course of radiotherapy. SCC patients showed higher levels of urinary 8-OHdG/creatinine than the controls. Furthermore, SCC patients with complete or partial response to the chemotherapy showed a significant decrease in urinary 8-OHdG/creatinine while patients with no change or progressive disease showed an increase.
机译:>尿中的8-hydroxy-2'-deoxyguanosine与尿中的肌酐之比(8-OHdG /肌酐)被认为是DNA氧化的良好生物学指标。在放疗和化疗期间,使用单克隆抗体N45.1通过酶联免疫吸附法评估了肺癌患者的尿中8-OHdG /肌酐水平。非小细胞癌(non-SCC)患者在放疗过程中尿中的8-OHdG /肌酐升高。 SCC患者的尿中8-OHdG /肌酐水平高于对照组。此外,对化疗有完全或部分反应的SCC患者尿中的8-OHdG /肌酐明显降低,而无变化或进行性疾病的患者则升高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号